Is Intellia Therapeutics, Inc. (NTLA) a Buy, Sell, or Hold?
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$13.04 USD
-$0.26 (-1.95%)
- Volume
- 3.92M
- Average Volume
- 6.91M
- Market Capitalization
- $1.46B
- P/E Ratio
- -3.68
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $28.25
- Year Low
- $7.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.10
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
31
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
20
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 246.75K
NTLA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
NTLA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Dube Michael P | officer: VP, Chief Accounting Officer | 2026-07-01 | S-Sale | 16.78 | 2026-07-06 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2026-07-02 | S-Sale | 18 | 2026-07-06 |
| Verwiel Frank | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Verwiel Frank | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| Keresty Georgia | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Keresty Georgia | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| GOODMAN JESSE | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| GOODMAN JESSE | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| Goff Brian | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Goff Brian | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| Cohen Fred E | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Cohen Fred E | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| CHASE WILLIAM J | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| CHASE WILLIAM J | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| Bhanji Muna | director | 2026-06-09 | A-Award | 0 | 2026-06-10 |
| Bhanji Muna | director | 2026-06-09 | A-Award | 12.89 | 2026-06-10 |
| LEONARD JOHN M | director, officer: President and CEO | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| LEONARD JOHN M | director, officer: President and CEO | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| BASTA JAMES | officer: EVP, General Counsel | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| BASTA JAMES | officer: EVP, General Counsel | 2026-03-02 | S-Sale | 13.78 | 2026-03-03 |
| BASTA JAMES | officer: EVP, General Counsel | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2026-03-02 | S-Sale | 13.78 | 2026-03-03 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2026-03-01 | A-Award | 13.78 | 2026-03-03 |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2026-03-01 | A-Award | 0 | 2026-03-03 |
| LEONARD JOHN M | director, officer: President and CEO | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| BASTA JAMES | officer: EVP, General Counsel | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| Cohen Fred E | director | 2026-01-05 | P-Purchase | 9.35 | 2026-01-07 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2026-01-05 | S-Sale | 9.21 | 2026-01-07 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-11 | M-Exempt | 6.83 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-11 | S-Sale | 9.49 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-12 | M-Exempt | 6.83 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-11 | S-Sale | 9.47 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-11 | S-Sale | 9.59 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-11 | M-Exempt | 6.83 | 2025-12-12 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-12-12 | M-Exempt | 6.83 | 2025-12-12 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-10-01 | S-Sale | 17.38 | 2025-10-03 |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2025-10-01 | S-Sale | 17.38 | 2025-10-03 |
| CHASE WILLIAM J | director | 2025-08-20 | P-Purchase | 10.03 | 2025-08-22 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2025-07-23 | S-Sale | 14.02 | 2025-07-25 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2025-07-01 | S-Sale | 9.82 | 2025-07-03 |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2025-07-02 | S-Sale | 9.95 | 2025-07-03 |
| GOODMAN JESSE | director | 2025-06-30 | S-Sale | 9.56 | 2025-07-02 |
| GOODMAN JESSE | director | 2025-07-01 | S-Sale | 9.23 | 2025-07-02 |
| Keresty Georgia | director | 2025-06-11 | A-Award | 0 | 2025-06-18 |
| Keresty Georgia | director | 2025-06-11 | A-Award | 8.37 | 2025-06-18 |
| Verwiel Frank | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Verwiel Frank | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| GOODMAN JESSE | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| GOODMAN JESSE | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| Goff Brian | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Goff Brian | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| Bhanji Muna | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Bhanji Muna | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| CHASE WILLIAM J | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| CHASE WILLIAM J | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| Cohen Fred E | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Cohen Fred E | director | 2025-06-11 | A-Award | 8.37 | 2025-06-13 |
| Bhanji Muna | director | 2025-04-29 | S-Sale | 8.5 | 2025-05-01 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2025-03-04 | S-Sale | 8.99 | 2025-03-04 |
| Clark Eliana | officer: EVP, Chief Technical Officer | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| BASTA JAMES | officer: EVP, General Counsel | 2025-03-01 | A-Award | 0 | 2025-03-04 |
| BASTA JAMES | officer: EVP, General Counsel | 2025-03-04 | S-Sale | 8.99 | 2025-03-04 |
| BASTA JAMES | officer: EVP, General Counsel | 2025-03-01 | A-Award | 10.09 | 2025-03-04 |
| Bhanji Muna | director | 2025-01-29 | S-Sale | 9.97 | 2025-01-31 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 0 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 13.4 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 57.71 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 40.75 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 32.66 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 27.33 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 18.3 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 14.58 | 2025-01-23 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 2025-01-13 | 134.06 | 2025-01-23 | |
| Dube Michael P | officer: VP, Chief Accounting Officer | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |
| BASTA JAMES | officer: EVP, General Counsel | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |
| Lebwohl David | officer: EVP, Chief Medical Officer | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |
| Hicks Derek | officer: EVP, Chief Business Officer | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |
| LEONARD JOHN M | director, officer: President and CEO | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |
| Sepp-Lorenzino Laura | officer: EVP, Chief Scientific Officer | 2025-01-03 | S-Sale | 12.18 | 2025-01-07 |